+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biochip Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • June 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855128
The global minimally invasive surgical devices market size was valued at USD 12.9 billion in 2022, driven by the increasing demand for personalized medicines across the globe. The market size is anticipated to grow at a CAGR of 11.84% during the forecast period of 2023-2031 to achieve a value of USD 35.4 billion by 2031.

Biochip: Introduction

Biochips, also known as microarrays or lab-on-a-chip devices, are miniaturized platforms that integrate multiple biological assays or tests onto a single chip. These chips are made up of solid surfaces, such as glass or silicon, on which a variety of biological molecules such as DNA, RNA, proteins, antibodies, or cells are immobilized. Biochips enable the simultaneous analysis of multiple biological targets, providing researchers with a powerful tool for various applications in genomics, proteomics, drug discovery, diagnostics, and personalized medicine.

The introduction of biochips has revolutionized the field of biomedical research and diagnostics. They have greatly accelerated the pace of scientific discovery by enabling high-throughput analysis, rapid screening, and large-scale data generation. With biochips, researchers can study gene expression, protein-protein interactions, genetic variations, and biomarker discovery in a more efficient and cost-effective manner.

Biochips have found widespread applications in various areas of research and healthcare. In genomics, they are used for gene expression profiling, genome-wide association studies, and DNA sequencing. In proteomics, biochips enable the study of protein interactions, protein expression, and post-translational modifications. In drug discovery, biochips facilitate high-throughput screening of potential drug candidates and target identification. In diagnostics, biochips are used for disease detection, monitoring of treatment response, and patient stratification.

Key Trends in the Global Biochip Market

There are several key trends in the market and some of them are:
  • Multiplexed Assays: There is a growing demand for biochips capable of conducting multiplexed assays, which allow simultaneous detection of multiple analytes in a single sample. Multiplexing offers advantages such as increased efficiency, reduced sample volume, and cost-effectiveness. Advances in biochip technology have enabled the development of highly multiplexed assays, facilitating complex research and diagnostics
  • Point-of-Care Applications: There is a growing interest in developing biochips for point-of-care applications, where rapid and on-site diagnostic testing is required. Portable and handheld biochip devices offer the potential for immediate and accurate disease diagnosis, monitoring, and treatment decision-making at the point of care. This trend is driven by the need for faster results, decentralized healthcare delivery, and improved patient outcomes
  • Personalized Medicine: The field of personalized medicine, which aims to provide targeted and individualized therapies based on a patient's genetic makeup, is driving the demand for biochips. Biochips enable the analysis of genetic variations, gene expression profiles, and biomarkers associated with specific diseases or treatment responses. This information can be used to guide personalized treatment decisions and improve patient outcomes

Global Biochip Market Segmentations

Market Breakup by Technology

  • Microarray
  • Microfluidics

Market Breakup by Type

  • DNA Chips
  • Lab-On-a-Chips
  • Protein Chips
  • Others

Market Breakup by Applications

  • Drug Discovery and Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Others

Market Breakup by End User

  • Hospitals and Diagnostic Centers
  • Academics and Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Biochip Market Scenario

The biochip market is a rapidly growing sector in the field of life sciences and diagnostics. Biochips, also known as microarrays, are miniaturized devices that enable the simultaneous analysis of a large number of biological molecules, such as DNA, RNA, proteins, and cells. They offer several advantages, including high throughput, multiplexing capabilities, and the ability to perform complex assays in a rapid and cost-effective manner.

The increasing demand for personalized medicine, advancements in genomic research, and the need for high-throughput screening techniques are driving the growth of the biochip market. Biochips find applications in various fields, including genomics, proteomics, drug discovery, diagnostics, and agricultural research. They are widely used in studying gene expression, identifying genetic mutations, detecting biomarkers, and profiling proteins.

The market for biochips is expanding globally, with North America, Europe, and Asia-Pacific being the major regions driving growth. The presence of well-established research institutions, a strong focus on precision medicine, and the availability of advanced healthcare infrastructure contribute to the market growth in these regions.

In conclusion, the biochip market is experiencing significant growth driven by advancements in technology, increasing applications in various sectors, and the rising demand for personalized medicine. With continuous innovations and advancements, biochips are poised to play a crucial role in revolutionizing research, diagnostics, and healthcare delivery.

Global Biochip Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Abbott Laboratories Inc
  • Agilent Technologies, Inc
  • PerkinElmer Inc
  • Fluidigm Corporation
  • Illumina, Inc
  • GE Healthcare Inc
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific, Inc
  • F. Hoffmann-La Roche AG
  • BioMérieux SA
  • HORIBA, Ltd
  • Randox Laboratories Ltd
  • OriGene Technologies, Inc
  • Cepheid (Danaher Corporation)
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biochip Market Overview
3.1 Global Biochip Market Historical Value (2016-2022)
3.2 Global Biochip Market Forecast Value (2023-2031)
4 Global Biochip Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Biochip Market Segmentation
5.1 Global Biochip Market by Technology
5.1.1 Market Overview
5.1.2 Microarray
5.1.3 Microfluidics
5.2 Global Biochip Market by Type
5.2.1 Market Overview
5.2.2 DNA Chips
5.2.3 Lab-On-a-Chips
5.2.4 Protein Chips
5.2.5 Others
5.3 Global Biochip Market by Applications
5.3.1 Market Overview
5.3.2 Drug Discovery and Development
5.3.3 Disease Diagnostics
5.3.4 Genomics
5.3.5 Proteomics
5.3.6 Others
5.4 Global Biochip Market by End User
5.4.1 Market Overview
5.4.2 Hospitals and Diagnostic Centres
5.4.3 Academics and Research Institutes
5.4.4 Biotechnology and Pharmaceutical Companies
5.4.5 Others
5.5 Global Biochip Market by Region
5.5.1 Market Overview
5.5.2 North America
5.5.3 Europe
5.5.4 Asia Pacific
5.5.5 Latin America
5.5.6 Middle East and Africa
6 North America Biochip Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Biochip Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Biochip Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.6 Australia
8.7 Others
9 Latin America Biochip Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Biochip Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.5 Others
16 Supplier Landscape
16.1 Abbott Laboratories Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 Agilent Technologies, Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 PerkinElmer Inc.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Fluidigm Corporation
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Illumina, Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 GE Healthcare Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Bio-Rad Laboratories Inc.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Thermo Fisher Scientific, Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 F. Hoffmann-La Roche AG
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 BioMérieux SA
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 HORIBA, Ltd.
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 QIAGEN N.V.
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 Randox Laboratories Ltd.
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
16.14 OriGene Technologies, Inc.
16.14.1 Financial Analysis
16.14.2 Product Portfolio
16.14.3 Demographic Reach and Achievements
16.14.4 Mergers and Acquisitions
16.14.5 Certifications
16.15 Cepheid (Danaher Corporation)
16.15.1 Financial Analysis
16.15.2 Product Portfolio
16.15.3 Demographic Reach and Achievements
16.15.4 Mergers and Acquisitions
16.15.5 Certifications
17 Global Biochip Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer Inc.
  • Fluidigm Corporation
  • Illumina, Inc.
  • GE Healthcare Inc.
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche AG
  • BioMérieux SA
  • HORIBA, Ltd.
  • Randox Laboratories Ltd.
  • OriGene Technologies, Inc.
  • Cepheid (Danaher Corporation)



Table Information